Area of research
Reproductive Medicine · Obstetrics and Gynecology
Research interest
Research interests include Medicine, Oncology, Chemotherapy, Ovarian cancer, Cancer, and Bevacizumab.
Lymphomas of the Vulva: A Review of the MITO Rare Cancer Group
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer
Primary neuroendocrine neoplasms of the vulva: A review of the MITO rare cancer group
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial
Randomized phase III trial on trabectedin (ET-743) single agent versus clinician’s choice chemotherapy in recurrent ovarian, primary peritoneal, or fallopian tube cancers of BRCA-mutated or BRCAness phenotype patients (MITO23).
Association of Chemotherapy Timing in Pregnancy With Congenital Malformation
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
Management of Bilateral Malignant Ovarian Germ Cell Tumors